BFSG LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.99M Sell
3,326
-39
-1% -$39.8K 0.35% 82
2026
Q1
$3.1M Buy
3,365
+28
+0.8% +$28.4K 0.29% 105
2025
Q4
$3.59M Sell
3,337
-119
-3% -$114K 0.35% 91
2025
Q3
$2.64M Buy
3,456
+268
+8% +$199K 0.26% 115
2025
Q2
$2.49M Buy
3,188
+229
+8% +$178K 0.28% 111
2025
Q1
$2.44M Buy
2,959
+42
+1% +$34.9K 0.3% 105
2024
Q4
$2.25M Buy
2,917
+272
+10% +$225K 0.26% 119
2024
Q3
$2.34M Buy
2,645
+35
+1% +$31.5K 0.27% 113
2024
Q2
$2.36M Sell
2,610
-31
-1% -$24.8K 0.3% 97
2024
Q1
$2.05M Buy
2,641
+276
+12% +$196K 0.27% 103
2023
Q4
$1.38M Buy
2,365
+1,315
+125% +$768K 0.2% 123
2023
Q3
$564K Buy
+1,050
New +$541K 0.09% 162

Other funds holding LLY

BFSG LLC's LLY Position: Q2 2026 in Review

BFSG LLC reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $39.8K and leaving 3,326 shares worth $3.99M. The position accounts for 0.35% of the portfolio, ranked #82.

BFSG LLC first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 903 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BFSG LLC held 3,326 shares of Eli Lilly worth $3.99M as of Q2 2026.
  • BFSG LLC sold 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.35% of BFSG LLC's portfolio in Q2 2026, its #82 holding.
  • BFSG LLC first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 903 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.